CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the role of a specific long non-coding RNA, RP3-340N1.2, in lung cancer progression and develops human serum albumin-based nanoparticles for targeted therapy. The aim is to improve treatment efficacy while minimizing side effects and drug resistance.
Lung cancer remains the most frequently diagnosed and most lethal cancer, making this disease a huge socio-economic challenge.
Therefore, new effective therapeutic approaches are urgently needed.
Long non-coding RNAs (lncRNAs) are versatile molecules that influence crucial pathways in cancer progression. RP3-340N1.2 is a poorly investigated but highly overexpressed lncRNA in lung cancer, suggesting it plays a pivotal role in its progression.
The fellow will investigate the role of RP3-340N1.2 in…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
